31 results
8-K
EX-10.1
i2hqu mvzjr1k272o
4 Nov 22
Entry into a Material Definitive Agreement
5:00pm
DEFR14A
zt5v0dj9p3 fq9p
12 May 22
Revised proxy
5:00pm
8-K
EX-14.1
3boihv
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
8-K
h04opc0uu9udecn cy
9 Aug 21
Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress
4:02pm
8-K
EX-99.1
w4k cpw0c9l5xnc22
9 Aug 21
Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress
4:02pm
8-K
EX-99.1
mzbavpde9506so
10 May 21
Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data
4:21pm
8-K
EX-1.1
j1v6r 6bxa20
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am